Phase IV, a Clinical Trial to Assess Safety and Convenience of the Change From DTG/3TC to BIC/FTC/TAF in People With HIV, Good Virological Control and Neuropsychiatric Vulnerabilities

NCT05549180 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: BIKTARVY 50Mg-200Mg-25Mg Tablet and Dovato placebo
DRUG: Dovato 50Mg-300Mg Tablet + Biktarvy placebo

Sponsor

Fundacion SEIMC-GESIDA